Research ArticleGout
The Cost-effectiveness of Biannual Serum Urate (SU) Monitoring after Reaching Target in Gout: A Health Economic Analysis Comparing SU Monitoring
Philip C. Robinson, Nicola Dalbeth and Peter Donovan
The Journal of Rheumatology May 2018, 45 (5) 697-704; DOI: https://doi.org/10.3899/jrheum.170199
Philip C. Robinson
From the departments of Rheumatology and Clinical Pharmacology, Royal Brisbane and Women’s Hospital; School of Medicine, University of Queensland, Brisbane,
Australia; Department of Medicine, University of Auckland, Auckland,
New Zealand.
Nicola Dalbeth
REFERENCES
- 1.↵
- 2.↵
- 3.↵
- Trieste L,
- Palla I,
- Fusco F,
- Tani C,
- Baldini C,
- Mosca M,
- et al.
- 4.↵
- 5.↵
- 6.↵
- 7.↵
- Riedel AA,
- Nelson M,
- Joseph-Ridge N,
- Wallace K,
- MacDonald P,
- Becker M
- 8.↵
- 9.↵
- 10.↵
- 11.↵
- Solomon DH,
- Avorn J,
- Levin R,
- Brookhart MA
- 12.↵
- Husereau D,
- Drummond M,
- Petrou S,
- Carswell C,
- Moher D,
- Greenberg D,
- et al.
- 13.↵
- 14.↵
- 15.↵
- 16.↵
- 17.↵
- 18.↵
- Robinson PC,
- Taylor WJ,
- Dalbeth N
- 19.↵
- Australian Government Department of Health
- 20.↵
- Australian Government Department of Health
- 21.↵
- Australian Government Department of Health
- 22.↵
- Australian Institute of Health and Welfare
- 23.↵
- The Australian Taxation Office
- 24.↵
- Khanna PP,
- Nuki G,
- Bardin T,
- Tausche AK,
- Forsythe A,
- Goren A,
- et al.
- 25.↵
- Australian Government Department of Health
- 26.↵
- Rees F,
- Jenkins W,
- Doherty M
- 27.↵
- 28.↵
- 29.↵
- 30.↵
- Piette JD,
- Weinberger M,
- Kraemer FB,
- McPhee SJ
- 31.↵
- 32.↵
In this issue
The Journal of Rheumatology
Vol. 45, Issue 5
1 May 2018
The Cost-effectiveness of Biannual Serum Urate (SU) Monitoring after Reaching Target in Gout: A Health Economic Analysis Comparing SU Monitoring
Philip C. Robinson, Nicola Dalbeth, Peter Donovan
The Journal of Rheumatology May 2018, 45 (5) 697-704; DOI: 10.3899/jrheum.170199